Registe-se para criar alertas sobre instrumentos,
eventos económicos e conteúdo por autores seguidos
Registo gratuito Já tem uma conta? Iniciar sessão
Cotações
Todos os tipos
- Todos os tipos
- Índices
- Ações
- ETFs
- Fundos
- Matérias-primas
- Moedas
- Criptomoedas
- Obrigações
- Certificados
Por favor, tente outra pesquisa
Poupe 50%! Supere o mercado em 2025 com a InvestingPro
OBTER OFERTA
Blackrock Global Funds - World Healthscience Fund A2 Aud Hedged (0P000127R4)
Adicionar/Remover de uma carteira
Adicionar à watchlist
21,090
+0,120
+0,57%
23/12 - Fechado. Moeda em AUD
Tipo:
Fundo
Mercado:
Luxemburgo
Emissor:
BlackRock (Luxembourg) SA
ISIN:
LU1023059063
Classe de Ativo:
Açao
- Classificação da Morningstar:
- Ativos Totais: 70,02M
BlackRock Global Funds - World Healthscience Fund
21,090
+0,120
+0,57%
Blackrock Global Funds - World Healthscience Fund A2 Aud Hedged - Vista Geral
Nesta página encontrará um perfil aprofundado de Blackrock Global Funds - World Healthscience Fund A2 Aud Hedged. Fique a saber mais sobre as pessoas-chave, o total de ativos, a estratégia de investimento e a informação de contacto de 0P000127R4, e mais.
Estratégia de investimento
O World Healthscience Fund visa maximizar a valorização do capital denominado em dólares americanos, investindo em acções cotadas de sociedades com interesses substanciais em tecnologia e fornecimentos de cuidados de saúde, farmacêuticos e médicos. O Fundo poderá também investir em sociedades dedicadas ao desenvolvimento da biotecnologia. O Fundo investe globalmente.
Informações de Contacto
Endereço
35 A, avenue J.F. Kennedy,
Luxembourg, L-1855
Luxembourg
Luxembourg, L-1855
Luxembourg
Telefone
+44 20 77433000
Fax
Amsterdam
Principais Executivos
| Nome | Título | Desde | Até |
|---|---|---|---|
| Xiang Liu | Director | 2020 | Agora |
| Biografia | Xiang Liu, PhD, Director, is a member of the Health Sciences team, part of BlackRock’s Active Equity Group. He is co-portfolio manager for the Health Sciences equity portfolios and is responsible for coverage of the medical devices & supplies sector. Prior to joining BlackRock in 2008, Mr. Liu was a partner and biotech analyst at Mehta Partners. From 2002 to 2005, he was a Director in the corporate development department at Cubist Pharmaceuticals. Mr. Liu began his investment career in 2000 at the Boston Consulting Group as a Healthcare consultant. Mr. Liu earned a BS degree in Chemistry from the University of Science & Technology, China in 1993, a PhD degree in Chemistry from Yale University in 1997, and a MBA degree in finance, strategy, and accounting from the University of Chicago in 2000. | ||
| Erin Xie | Managing Director | 2011 | Agora |
| Biografia | Erin Xie, PhD, Managing Director and portfolio manager, is the head of the Health Sciences team, part of BlackRock’s Active Equity Group. She is the lead portfolio manager for the Health Sciences equity portfolios. Ms. Xie's service with the firm dates back to 2001, including her years with State Street Research & Management (SSRM), which merged with BlackRock in 2005. At SSRM, she was a Senior Vice President and portfolio manager responsible for managing the State Street Health Sciences Fund. Prior to joining State Street Research in 2001, Ms. Xie was a research associate with Sanford Bernstein covering the pharmaceutical industry from 1999. From 1994 until 1997, she was a post doctoral research scientist at Columbia University. Ms. Xie earned a BS degree in chemistry from Beijing University in 1988, a PhD degree in Biochemistry from the University of California, Los Angeles, in 1993 and a MBA degree from the Massachusetts Institute of Technology Sloan School of Management in 1999. | ||
| Jeff Lee | - | 2020 | 2023 |
| Biografia | Jeffrey Lee, Director, is a member of the Health Sciences team, part of BlackRock’s Active Equity Group. He is co-portfolio manager for the Health Sciences equity portfolios and is responsible for coverage of the healthcare providers and services sector. Prior to joining BlackRock in 2011, Mr. Lee was a member of the healthcare investment team at Duquesne Capital Management where he covered provider and service companies. From 2006 to 2008, Mr. Lee was an healthcare private equity associate at Altaris Capital Partners where he sourced and analyzed equity transactions for public and private healthcare companies. Prior to 2006, Mr. Lee was an analyst at Citigroup within the healthcare finance and investment banking group where he valued and helped structured financing for managed care providers, hospital companies and other large healthcare systems. Mr. Lee earned a BA degree in economics, cum laude, from Princeton University in 2004. | ||
| Thomas P. Callan | Managing Director | 2011 | 2017 |
| Biografia | Thomas P. Callan, CFA, Managing Director and senior portfolio manager, is head of BlackRock's Global Opportunities equity team. He oversees the team's investment process, leads the team's Investment Strategy Group, and provides portfolio and risk management oversight for all of the team's products. In addition, Mr. Callan is a member of BlackRock's Leadership Committee. Mr. Callan's service with the firm dates back to 1988, including his years with PNC Asset Management Group, which was integrated with BlackRock in 1998. He started as a health care analyst for PNC's mutual fund group and later served as an international equity analyst. Mr. Callan began his investment career at PNC Bank as a personal trust portfolio manager in 1988. Mr. Callan earned a BA degree in economics, with honors, from Boston College in 1981. | ||
| Bob Hodgson | - | 2005 | 2011 |
Escreva o que você pensa sobre Blackrock Global Funds - World Healthscience Fund A2 Aud Hedged
Tem certeza que deseja eliminar este gráfico?
Eliminar Cancelar
Substituir o gráfico anexado por um novo gráfico?
Substituir Cancelar
Diretrizes para Comentários
Anexar um gráfico a um comentário
Confirmar Bloqueio
Quer mesmo bloquear %USER_NAME%?
Se o fizer, não poderá consultar as mensagens de %USER_NAME% e vice versa em Investing.com.
Adicionou %USER_NAME% com sucesso à sua Lista de Bloqueios
Uma vez que acabou de desbloquear esta pessoa, deve aguardar 48 horas antes de bloqueá-la novamente.
Denunciar este comentário
Diga-nos o que achou deste comentário
Comentário denunciado
Obrigado!
Seu comentário foi enviado aos moderadores para revisão